|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 11.26 USD | -12.17% |
|
-11.69% | +67.56% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.86B | - | ||||
| 65B | |||||
| 51.19B | |||||
| 51.2B | |||||
| 43.93B | |||||
| 41.96B |
- Stock Market
- Stocks
- NVAX Stock
- Charts Novavax, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
